Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 15/04/20111 min de lecture
Determination of Regulatory Review Period for Purposes of Patent Extension; ATRYN; Correction
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of March 21, 2011 (76 FR 15323). The document announced the determination of the regulatory review period for ATRYN. The document was published with an incorrect docket number. This document corrects that error.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →